Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|July 11, 2026
Dissecting Cancer Metabolism and Therapeutic Resistance Using In Vitro PlatformsBruna Abreu, Isabel Lemos, Jacinta SerpaAdvances in Experimental Medicine and Biology|July 11, 2026
Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer MetabolismCatarina Freitas-Dias, Isabel Lemos, Stefano Mazzoleni, et al.Cells|February 23, 2024
Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTECatarina Freitas-Dias, Filipe Gonçalves, Filipa Martins, et al.Lung Cancer (Amsterdam, Netherlands)|June 28, 2023
NSCLC presents metabolic heterogeneity, and there is still some leeway for EGF stimuli in EGFR-mutated NSCLCCindy Mendes, Isabel Lemos, Inês Francisco, et al.Veterinary and Comparative Oncology|March 6, 2020
Tn and Sialyl-Tn antigens in canine gastric tissuesAna R Flores, Isabel Lemos, Alexandra Rema, et al.Metabolites|April 25, 2025
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific MannerIsabel Lemos, Catarina Freitas-Dias, Ana Hipólito, et al.Metabolites|April 25, 2025
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell LineIsabel Lemos, Catarina Freitas-Dias, Ana Hipólito, et al.Molecules (Basel, Switzerland)|July 12, 2025
Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic TargetingBárbara Ferreira, Isabel Lemos, Cindy Mendes, et al.Bioscience Reports|July 11, 2024
Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cellsCindy Mendes, Isabel Lemos, Ana Hipólito, et al.Antioxidants (Basel, Switzerland)|January 22, 2024
H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized MedicineAna Hipólito, Cindy Mendes, Filipa Martins, et al.Pageof 2